Combination medicine for improving anti-HBV curative effect of interferon and preparation method of combination medicine

The invention discloses a combination medicine for improving an anti-HBV curative effect of interferon. The combination medicine comprises the following raw materials by weight: 20-40g of astragalus membranaceus, 20-40g of rhizoma atractylodis macrocephalae, 5-15g of ganoderma lucidum, 5-15g of codonopsis pilosula, 5-15g of American ginseng, 5-15g of radix pseudostellariae, 5-15g of divaricate saposhnikovia root, 10-30g of radix scrophulariae, 10-30g of radix sophorae flavescentis, 10-20g of polygonum cuspidatum, 10-20g of phyllanthus ruinaria, 10-20g of serissa serissoide, 5-15g of Chinese gall, 20-40g of red peony root, 10-30g of sedum sarmentosum, 5-15g of schisandra chinensis, 10-20g of radix bupleuri, 10-20g of buchnera, 4-8g of human placenta (superfine powder) and 4-8g of liquorice. According to the medicine prepared by the combination medicine for improving the anti-HBV curative effect of the interferon and a preparation method of the combination medicine, the combination medicine is named decoction for benefiting qi, strengthening the body resistance and detoxifying. Through clinical verification, a good effect is obtained by combining anti-HBV of the interferon. The clinical research proves that the combination medicine for improving the anti-HBV curative effect of the interferon is precise and appropriate in composition, outstanding in curative effect, and free of a toxic or side effect and bad reaction, and has relatively good popularization value and prospect.